key: cord-0812013-vjl6pb85
authors: Waldum, Helge; Martinsen, Tom Christian
title: Chronic diseases: what about infections of virus and prions via the gut?
date: 2021-09-28
journal: Therap Adv Gastroenterol
DOI: 10.1177/17562848211028805
sha: 0a67416184d2299e45b01474a51cb7cfff0f04ae
doc_id: 812013
cord_uid: vjl6pb85

nan

The gut bacterial microbiome has been studied extensively and quantitative differences have been attributed to different conditions and diseases. However, interest has been concentrated on bacteria and no other microorganisms. During the last decade methodological improvements have made it possible to study virus and other microorganisms. [1] [2] [3] Since the description of Mad Cow Disease being transmitted to man by food, 4, 5 we have wondered about the lack of interest in gut virus and prions by the medical community. 6 In spite of the lack of knowledge of the aetiology of chronic infectious disease like inflammatory bowel disease, so-called neurodegenerative diseases and most cancers, few if any have been concerned about the risk of installing faeces into the gut to treat irritable bowel syndrome, 7 or even neurological diseases, 8 based on a belief that only known bacterial pathogens could play any pathogenic role and that observations for a few months could secure safety. Taking into consideration the known latency between infection and development of cancer as well as prion diseases, 9,10 such a view reflects a naivety and lack of biological knowledge. In fact, one of us wrote a paper 40 years ago that most of the chronic inflammatory and neoplastic diseases in the gastrointestinal tract were of viral origin. 11 Recently, the possible role of virus in chronic inflammatory bowel disease as well as gastrointestinal cancer, including colonic cancer, has been discussed. [12] [13] [14] Many years ago, we published our papers on the role of gastric juice in the defence against prion diseases, 15,16 without attracting any interest at all. In general, the role of normal gastric juice in the defence against infections including virus has not been focussed on, although viruses having the property to escape destruction by gastric juice were classified as enterovirus (poliovirus belongs to this group). Together with the proteolytic enzyme pepsin, and possibly also the gastric lipase, the gastric acid is central to the destruction of microbes. 17 Use of inhibitors of gastric acid secretion will accordingly reduce the ability of gastric juice to kill swallowed microorganisms and possibly by this mechanism increase the risk of diseases with unknown aetiology, including cancers. Use of proton pump inhibitors (PPIs) has been claimed safe from observation studies of a few years without discussing these aspects, 18 and an accompanying leader declared that the question of PPI toxicity was solved. 19 We hope that the focus on the virome will lead to increased caution and vigilance when it comes to use of inhibitors of gastric acid secretion as well as installation of faeces in the gut.

The authors declare that there is no conflict of interest.

The authors received no financial support for the research, authorship, and/or publication of this article.

Helge Waldum https://orcid.org/0000-0002-3137-0843

The gut virome: the 'missing link' between Therapeutic Advances in Gastroenterology 14 2 journals.sagepub.com/home/tag gut bacteria and host immunity?

Review article: the human intestinal virome in health and disease

Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19. Gut. Epub ahead of print 26

Variant Creutzfeldt-Jakob disease

The same prion strain causes vCJD and BSE

Gastric juice: a barrier against infectious diseases

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study

Fecal microbiota transplantation in neurological disorders

Epidemiology of Helicobacter pylori infection

The epidemiology of kuru: monitoring the epidemic from its peak to its end

Gastritis, peptic ulcer disease, inflammatory bowel disease, and stomach and colon cancersare they all caused by viral infections?

Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease

Enteric virome and carcinogenesis in the gut

The gut virome: a neglected actor in colon cancer pathogenesis

Gastric acidity protects mice against prion infection?

Inhibitors of gastric acid secretion increase the risk of prion infection in mice

Bacterial killing in gastric juice-effect of pH and pepsin on Escherichia coli and Helicobacter pylori

Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin

Safety and complications of longterm proton pump inhibitor therapy: getting closer to the truth